Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-11 | 2026-03-09 | ANIK | McLeod Ian | SVP, CAO, Treas | F - Tax | $14.96 | -639 | 18.7K | -3% | -$9,559 |
| D | 2026-03-11 | 2026-03-09 | ANIK | McLeod Ian | SVP, CAO, Treas | M - OptEx | — | +2,197 | 19.4K | +13% | — |
| D | 2026-03-11 | 2026-03-09 | ANIK | McLeod Ian | SVP, CAO, Treas | M - OptEx | $0.00 | -2,197 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | F | D | 639 | $14.96 | 18,744 | D | — | — | (F3) Reflects an aggregate of 639 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026. |
| 2 | Common | Common Stock | 2026-03-09 | M | A | 2,197 | — | 19,383 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F2) Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 528 shares purchased on May 14, 2025 and 616 shares purchased on November 14, 2025. |
| 3 | Derivative | Restricted Stock Unit | 2026-03-09 | M | D | 2,197 | $0.00 | 0 | D | — · — to — | 2,197 Common Stock | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F4) On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award. |